Abstract
A 45-year-old female patient was admitted to a headache clinic because she experienced an increase of frequency in her known migraine without aura attacks. Since puberty, she suffered from menstrual migraine attacks with a duration of 3–4 days. The attacks were accompanied by nausea, photophobia, and phonophobia. In the first years, she took paracetamol or acetylsalicylic acid to treat the attacks which was of limited success; often 5–10 tablets were needed during the headache period. After introduction of the triptans, she switched to sumatriptan 100 mg tablets which gave her relief for a whole day; later she took also zolmitriptan 5 mg. She never was put on a short-term prophylaxis or other prophylactic treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Buse DC, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB (2013) Psychiatric comorbidities of episodic and chronic migraine. J Neurol 260:1960–1969
Cianchetti C, Pruna D, Ledda M (2013) Epileptic seizures and headache/migraine: a review of types of association and terminology. Seizure 22:679–685
Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor P (2009) EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force. Eur J Neurol 16:968–981
Katsarava Z, Weimar C (2010) Migraine and stroke. J Neurol Sci 299:42–44
Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013) Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev (6):CD010608
Mehle ME (2012) Migraine and allergy: a review and clinical update. Curr Allergy Asthma Rep 12:240–245
Nappi RE, Nappi G (2012) Neuroendocrine aspects of migraine in women. Gynecol Endocrinol 28(Suppl 1):37–41
Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R (2005) The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 45:144–152
Sathe S (2013) Migraine and neurogenetic disorders. Curr Pain Headache Rep 17:360
Schwedt TJ (2009) The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurol Clin 27:513–523
Stovner LJ et al (2013) A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia 34:523–532
Tronvik E et al (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289:65–69
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Evers, S. (2015). Migraine Patients with Comorbid Disorders and Their Management. In: Siva, A., Lampl, C. (eds) Case-Based Diagnosis and Management of Headache Disorders. Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-06886-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-06886-2_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06885-5
Online ISBN: 978-3-319-06886-2
eBook Packages: MedicineMedicine (R0)